4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-26-000036
Chief Legal Officer acquired 41,343 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Van Tuyl Christopher Chief Legal Officer | 2026-04-07 | Grant or award | +41,343 | 188,396 | D | ||
| Derivatives | |||||||
| Van Tuyl Christopher Chief Legal Officer | 2026-04-07 | Grant or award · Stock Option (right to buy) | +59,820 | 59,820 | D | ||
Loading xslF345X06/wk-form4_1775765844.xml…